European Case Law Identifier: | ECLI:EP:BA:2019:T084214.20190123 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 23 January 2019 | ||||||||
Case number: | T 0842/14 | ||||||||
Application number: | 03767188.0 | ||||||||
IPC class: | C12Q 1/68 | ||||||||
Language of proceedings: | EN | ||||||||
Distribution: | D | ||||||||
Download and more information: |
|
||||||||
Title of application: | IMPROVED COMPOSITIONS FOR IN VITRO AMPLIFICATION OF NUCLEIC ACIDS | ||||||||
Applicant name: | QIAGEN Beverly, Inc. | ||||||||
Opponent name: | Zwicker, Jörk | ||||||||
Board: | 3.3.08 | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: |
|
||||||||
Keywords: | Main request and auxiliary request 1 - Novelty (no); Auxiliary request 2 - added subject-matter (yes); Auxiliary request 3 - clarity (no); Auxiliary request 4 - sufficiency of disclosure (no); Auxiliary request 5 - admitted into the proceedings (no); Auxiliary request 6 - clarity (no), sufficiency of disclosure (no); |
||||||||
Catchwords: |
- |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t140842eu1.html
Date retrieved: 17 May 2021